These pathological variants are found in EE patients and we used recombinant human ETHE1 proteins to address how these changes influence the catalytic properties and conformational stability of the protein, using a series of biophysical and biochemical assays. The gene discussed is ETHE1; the disease is ethylmalonic encephalopathy.